57 results
8-K
EX-1.1
CPRX
Catalyst Pharmaceuticals Inc
5 Jan 24
Catalyst Pharmaceuticals, Inc. Announces Proposed Public Offering of Common Stock
5:23pm
, reasonably be expected to result in a Material Adverse Effect, there has been no security breach or incident, unauthorized access or disclosure, or other … no knowledge of any event or condition that could reasonably be expected to result in, any security breach or incident, unauthorized access
424B5
o9zia pz2q6qqt
11 Sep 19
Prospectus supplement for primary offering
5:18pm
424B5
nxcofz0yg x6ax4y
27 Nov 17
Prospectus supplement for primary offering
12:00am
424B3
rabz z6s67
27 Aug 15
Prospectus supplement
12:00am
424B5
hny52 88r
4 Feb 15
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
nf6r3zc ug12tj
4 Feb 15
Announces Commencement of Public Offering of Common Stock
12:00am
424B5
vvi7gp65 ym
3 Feb 15
Prospectus supplement for primary offering
12:00am
424B5
3sdwp4r7df
3 Apr 14
Prospectus supplement for primary offering
12:00am
8-K
EX-1.1
547koxdjbaogyq
3 Apr 14
Announces Commencement of Public Offering of Common Stock
12:00am
424B5
6pi thg7tno1o4
2 Apr 14
Prospectus supplement for primary offering
12:00am
424B3
s4qqbrwiuv
20 Mar 14
Prospectus supplement
12:00am